Publicacións nas que colabora con Ricardo Blanco Alonso (28)

2024

  1. Inflammasome-Related Genetic Polymorphisms as Severity Biomarkers of COVID-19

    International Journal of Molecular Sciences, Vol. 25, Núm. 7

  2. Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients

    RMD open, Vol. 10, Núm. 2

2023

  1. Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients

    Seminars in Arthritis and Rheumatism, Vol. 58

  2. Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism

    Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 910-915

  3. Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway

    Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 864-869

  4. E-Selectin, ICAM-1, and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  5. Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  6. Epidemiology and clinical domains of Behçet's disease in the Cantabria region, Northern Spain

    Clinical and experimental rheumatology, Vol. 41, Núm. 10, pp. 1991-1997

  7. Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

  8. Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients

    Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 829-836

  9. Reply to: New-onset aortitis manifesting as relapsing giant cell arteritis successfully managed with tocilizumab monotherapy. by Guarda et al

    Clinical and experimental rheumatology

  10. Systemic treatment in sarcoidosis: Experience over two decades

    European Journal of Internal Medicine, Vol. 108, pp. 60-67

  11. Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review

    RMD open, Vol. 9, Núm. 1

2022

  1. Baricitinib in severe and refractory peripheral ulcerative keratitis: a case report and literature review

    Therapeutic Advances in Musculoskeletal Disease, Vol. 14

  2. Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review

    Therapeutic Advances in Musculoskeletal Disease, Vol. 14

  3. Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review

    European Journal of Internal Medicine, Vol. 101, pp. 86-92

  4. IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms

    Journal of Clinical Medicine, Vol. 11, Núm. 19

  5. Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register

    RMD Open, Vol. 8, Núm. 2

  6. Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients

    Therapeutic Advances in Musculoskeletal Disease, Vol. 14

2021

  1. Moderate and high disease activity predicts the development of carotid plaque in rheumatoid arthritis patients without classic cardiovascular risk factors: Six years follow-up study

    Journal of Clinical Medicine, Vol. 10, Núm. 21